4//SEC Filing
Shiferman Gregory L. 4
Accession 0001562180-25-000438
CIK 0001597553other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 4:12 PM ET
Size
9.5 KB
Accession
0001562180-25-000438
Insider Transaction Report
Form 4
Shiferman Gregory L.
See Remarks
Transactions
- Award
Stock Option (Right to buy)
2025-01-16+28,000→ 28,000 totalExercise: $6.97Exp: 2035-01-16→ Common Stock (28,000 underlying) - Award
Common Stock
2025-01-16+14,000→ 33,888 total
Footnotes (2)
- [F1]Consists of shares of common stock issuable under 14,000 restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. These RSUs are scheduled to vest in equal annual installments over four years with the first installment vesting on January 16, 2026.
- [F2]The securities awarded on January 16, 2025 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. Options to purchase 7,000 shares of common stock shall vest on the one year anniversary of January 16, 2025, with 21,000 shares vesting in 36 equal monthly installments thereafter.
Issuer
Sage Therapeutics, Inc.
CIK 0001597553
Entity typeother
Related Parties
1- filerCIK 0002041689
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 4:12 PM ET
- Size
- 9.5 KB